Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-29

Clinical Trial Update: Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two immunosuppressive strategies for renal function in chronic kidney disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Poitiers University Hospital | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED